Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | 1047208234@qq.com |
| QQ: | 1047208234 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3-(2-methoxyethyl)-5-(3-phenylpropyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid | Details |
| 3-(Bromomethyl)-2-cyclopropyl-4-(4'-fluorophenyl)quinoline | C19H15BrFN | 154057-56-4 | Details |
| Docetaxel Impurity D | C43H51NO14 | 167074-97-7 | Details |
| (RS)-2-(3-benzoylphenyl)propanamide | C16H15NO2 | 59512-16-2 | Details |
| 1-chloro-10-iododecane | C10H20ClI | 57152-87-1 | Details |
| Sinitopine impurities | 343878-57-9 | Details |
| 2-(2-Aminoethyl)benzenesulfonamide | C8H12N2O2S | 933705-21-6 | Details |
| C29H38N4O7 | 2272886-35-6 | Details |
| Lemborexant Impurity V-2 | C17H17FN2O3 | 2541020-22-6 | Details |
| Adenosylmethionine Impurity A (hydrochloride) | Details |
| piperacillin impurity Y | Details |
| Amlodipine besylate impurity G | C17H18ClNO4 | 43067-01-2 | Details |
| Mivacurium Chloride Impurity C | C33H46NO9+ | Details |
| Dodecyl Acetate | C14H28O2 | 112-66-3 | Details |
| (3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-1-oxidized quinoline-3-yl)-3,5-dihydroxyheptyl6-enol sodium salt | C25H25FNNaO5 | 2276678-27-2 | Details |
| Abemaciclib Impurity | C21H18F2N6O | 1627082-92-1 | Details |
| L-Tartaric Acid Monoethyl ester Sodium Salt | C6H10O6 | 608-89-9 | Details |
| C22H24N4O8 | 28698-93-3 | Details |
| C27H33N3O8 | 885112-31-2 | Details |
| Orlistat Open Ring Impurity (2S,3S,5S)-Isomer | C29H55NO6 | 130676-66-3 | Details |
| No flupitivat triphenylphosphine | Details |
| 15-Keto BiMatoprost | C25H35NO4 | 1163135-96-3 | Details |
| Rivastiin bitartrate EP impurity G | C9H12O2 | 23308-82-9 | Details |
| (2-hydroxyethyl)ammonium dodecylsulphate | C14H33NO5S | 4722-98-9 | Details |
| 4-(Pyridin-3-ylsulfonyl)morpholine | C9H12N2O3S | 26103-48-0 | Details |
| C27H35N3O7 | 488818-72-0 | Details |
| Docetaxel Impurity E | C43H53NO14 | 153381-68-1 | Details |
| Ilaprazole Impurity P2-4 | Details |
| Ace chloride nitrogen oxide control | C9H12ClNO2 | 848694-10-0 | Details |
| Cangrelor tetrasodium impurity C-3 | C16H22F3N5O4S2 | 163706-58-9 | Details |
| Impurity I (clindamycin B palmitate) | C33H61ClN2O6S | 68206-99-5 | Details |
| Fexofenadine Impurity C | C31H39NO2 | 185066-37-9 | Details |
| (R)-7-(benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C31H25F2N3O4S | 1985606-53-8 | Details |
| Clopidogrel Related Compound III | C16H18ClNO6S2 | 120202-71-3 | Details |
| (4-Methoxy-3-methylpyridin-2-yl)methanol | C8H11NO2 | 86604-77-5 | Details |
| C29H40N4O7 | 601455-29-2 | Details |
| (S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazo-2-yl)-2-methylpyrrolidine-1-yl)(5-methoxy-2-(1H-1,2,3-triazole-1-yl)phenyl)methyl ketone | Details |
| [3-[(1S)-1-[Methyl(nitroso)amino]ethyl]phenyl] N-ethyl-N-methyl carbamate | Details |
| Content of 4-oxo-2-phenylbutanoic Acid (IPT-III-A) | C10H10O3 | 5894-79-1 | Details |
| 4-(pyridin-2-ylsulfonyl)morpholine | C9H12N2O3S | 106762-44-1 | Details |
| Sodium Cyclopropanesulfinate | C3H7NaO2S | 910209-21-1 | Details |
| Content of 8-(propan-2-yl)-8-azabicyelo [3.2.1]oct-3-yl-3-oxo-2-phenylpropanoate(IPT-III-B) | C19H25NO3 | 22235-74-1 | Details |
| Ilaprazole Impurity 3 | C20H18N5OS | 2285346-43-0 | Details |
| 4-Amino-N-nitroso-N-methylaniline | Details |
| Sodium pantothenate impurity E calcium salt | Details |
| Fmoc-β-Ala-Aph(Hor)-OH | Details |
| 10-Iodo-1-decanol | C10H21IO | 57395-49-0 | Details |
| STJ enantiomers | C19H14F2N6O | 1207456-00-5 | Details |
| Enalapril maleate Impurity A | C20H28N2O5 | 76420-74-1 | Details |
| 2-(3-(2,4,5-trimethylbenzoyl)phenyl)propanoic acid | C19H20O3 | 1797984-80-5 | Details |
| 2-(3-(2,3,4-trimethylbenzoyl)phenyl)propanoic acid | C19H20O3 | 1785760-29-3 | Details |
| 2-isopropyl-5-methylcyclohexyl-2-(3-benzoylphenyl)propionate | C26H32O3 | 1853132-06-5 | Details |
| Benzophenone Azine | C26H20N2 | 983-79-9 | Details |
| 3-(2-Aminoethyl)benzenesulfonamide | C8H12N2O2S | 81760-42-1 | Details |
| Fmoc-D-Aph(Cbm)-D-Aph(Cbm)-OH | Details |
| Fmoc-Aph(Hor)-Aph(Hor)-OH | Details |
| Hydroxyethyl phthalylamlodipine | C30H34ClN3O8 | 3079028-35-3 | Details |
| Ibrutinib Intermediate 2 Impurities 19 | Details |
| Ilaprazole Impurity P1-4 | Details |
| Rivastiin bitartrate EP impurity F | C11H17NO | 889443-69-0 | Details |
| Rivastiin bitartrate USP impurity | C10H12N2O4 | 1346242-31-6 | Details |
| Cangrelor tetrasodium impurity C-1 | C16H23F3N5O7PS2 | 847460-53-1 | Details |
| Linagliptin Impurity 34 | C27H30N8O3 | Details |
| Rizatriptan EP Impurity B | Details |
| Ibuprofen Impurity K | C10H10O3 | 43153-07-7 | Details |
| (S)-(+)-3-Quinuclidinol | C7H13NO | 34583-34-1 | Details |
| Allyl acetoacetate | C16H22O10 | 27741-01-1 | Details |
| BHA biphenyl type dimer | C22H30O4 | 14078-41-2 | Details |
| 3,5-Bis(benzene-2-propyl)2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid | Details |
| Sodium pantothenate impurity H | Details |
| Ilaprazole Impurity SM2-7 | C7H8ClNO | 59886-85-0 | Details |
| (1R,2S)-2-[[(2,4-dimethyl-5-pyrimidine)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridyl)cyclopropaneformamide (Leborethen) | C22H20F2N4O2 | 1369764-02-2 | Details |
| Cis-oxidation (Z)-Dehydro Cilnidipine | C27H26N2O7 | 146845-35-4 | Details |
| Bemeprost C1 acid | C23H32O5 | 38344-08-0 | Details |
| Decyl Acetate | C12H24O2 | 112-17-4 | Details |
| bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | C21H26N2O8 | 70172-96-2 | Details |
| 5-Methylisoxazole-3-carboxamide | C5H6N2O2 | 3445-52-1 | Details |
| C28H38N4O7 | 2272886-38-9 | Details |
| C30H42N4O7 | 488819-64-3 | Details |
| N,N'-(ethane-1,2-diyl)bis(N-methylnitrous amide) | C4H10N4O2 | 13256-12-7 | Details |
| 3-Ethyl-4-methyl-1H-pyrrole-2,5-dione | C7H9NO2 | 20189-42-8 | Details |
| 4-Nitrophenylethyl(methyl)carbamate | C10H12N2O4 | 90870-20-5 | Details |
| Fmoc-β-Ala-Aph(Cbm)-OH | Details |
| Prucalopride Impurity 2 | C17H24ClN3O3 | 1599434-55-5 | Details |
| Mivacurium Chloride Impurity D | C33H46NO9+ | Details |
| 1,3-dihydroxypropan-2-yl 2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoate | C18H19FO4 | 124635-86-5 | Details |
| 2-(methyl(nitroso)amino)acetic acid | C3H6N2O3 | 13256-22-9 | Details |
| 3-Methyl-isoxazole-5-carboxylic acid | C5H5NO3 | 4857-42-5 | Details |
| (R)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | 2163287-88-0 | Details |
| 1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aS)- | C17H17N3O4 | 2762066-94-2 | Details |
| 2,4-Decadienal | C10H16O | 2363-88-4 | Details |
| 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methylpyridin-1-ium Iodide | 131988-19-7 | Details |
| 6-(2-chloro-5-fluoropyrimidine-4-yl)-4-fluoro-2-methyl-1H-benzo[d]imidazole | Details |
| Domperidone Impurity F | C37H42Cl2N8O3 | 1391053-55-6 | Details |
| Flurbiprofen Impurity B | C18H17FO4 | 1797883-74-9 | Details |
| (4-Amino-phenyl)-methyl-carbamic acid tert-butyl ester | C12H18N2O2 | 1092522-02-5 | Details |
| 3-Benzoylphenylacetonitrile | C15H11NO | 21288-34-6 | Details |
| C15H30O3 | 93925-36-1 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 | ||||